Medicine & Life Sciences
Randomized Controlled Trials
100%
SARS Virus
92%
Coronavirus
91%
Placebos
81%
Random Allocation
78%
Metformin
71%
Sample Size
71%
Neutralizing Antibodies
58%
Fluvoxamine
52%
Severe Acute Respiratory Syndrome
51%
Ivermectin
51%
Medical Futility
48%
Spinal Cord Stimulation
48%
Outpatients
47%
Safety
46%
Clinical Trials, Phase I
44%
Losartan
43%
Therapeutics
43%
Monoclonal Antibodies
41%
Mortality
38%
Out-of-Hospital Cardiac Arrest
38%
Odds Ratio
35%
Confidence Intervals
34%
Inpatients
34%
Clinical Trials
33%
Intention
32%
Equipment and Supplies
31%
Spinal Cord Injuries
30%
Vaccination
30%
GS-5734
30%
Anhedonia
30%
Cardiopulmonary Resuscitation
29%
Bayes Theorem
29%
Heart Arrest
27%
Ventricular Fibrillation
27%
Meta-Analysis
27%
Professional Practice Gaps
26%
Viral Load
26%
Hypertension
25%
Equipment Design
25%
Simulation Training
24%
Extracorporeal Membrane Oxygenation
24%
Renin-Angiotensin System
24%
Survival
23%
Advanced Cardiac Life Support
23%
Phase II Clinical Trials
22%
Lung Injury
21%
Heart-Assist Devices
21%
Paraplegia
21%
Myelodysplastic Syndromes
20%
Mathematics
Q-learning
75%
Design
64%
Phase I Trial
55%
Clinical Trials
55%
Randomized Trial
54%
Toxicity
42%
Treatment Effects
35%
Covariates
34%
Model Misspecification
33%
Bayesian Model
32%
Optimization Design
29%
Evaluate
29%
Randomized Controlled Trial
26%
Bayesian Learning
26%
Group Sequential
26%
Bayesian Design
26%
Bayesian Hierarchical Model
25%
Bayesian Variable Selection
25%
Oncology
25%
Progression
25%
Survival Model
24%
Historical Data
24%
Lung Cancer
24%
Randomisation
24%
Simulation
24%
Surveillance
23%
Cooling
23%
Diagnostic Tests
22%
Gold
22%
Competing Risks
22%
Functional Data
21%
Repeated Measures
21%
Model
20%
Assignment
20%
Chemotherapy
20%
Survival Data
20%
Hazard
20%
Batch
20%
Machine Learning
19%
Logistics
18%
Market
18%
Shock
17%
Standards
17%
Categorical
16%
Severe Acute Respiratory Syndrome
16%
Simulation Study
16%
Decision Rules
16%
Type I error
16%
Modeling
15%